Daily FNArena News

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

A glance through the latest expert views and predictions about commodities: potential impact on iron ore from trade tensions; gold sector stock preferences & the outlook for a range of commodities

All eyes on 7910, reports Tony Sycamore, Market Analyst, IG, as that is the signal 8000 should come into focus

Gentrack is emerging as a potential key player in the cloud native, SaaS based utility meters sector, where utilities are under invested and thus requiring a major upgrade cycle, in the transition to sustainability and net zero emissions

Jumbo Interactive has been benefiting from a run of big lottery jackpots, but is this a trend or a blip? Citi has concerns, initiating coverage with a Sell rating

Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, the ASX200 and WTI crude oil

In the wake of Telix Pharmaceuticals’ non-IPO on the Nasdaq, FNArena shines a light on the company’s fortunes and that of Australian biotech and cancer research generally

Michael Gable of Fairmont Equities sees Fortescue shares recovering from current oversold conditions

Analysts highlight structural tailwinds for Ventia Services and margin protection from contract mix and flexible costs

Independent Investment Research updates developments among Australia’s listed investment companies and provides comparative data